radiation exposure. There are about 54,270 new cases of leukemia in the U. S. annually. Leukemia
makes up about 3% of all new cancer cases. According to the World Cancer Research Fund, one
third of the cancer cases occur in economically developed economies such as US and Europe,
owing to lack of physical activity, obesity, and/or poor nutrition. Furthermore, around 90% of the
leukemia occur in the middle age and develop with the aging.
Furthermore, in emerging economies of Asia Pacific such as China and India, the leukemia
therapeutics market is expected to grow at significant rate due high unmet medical needs. However,
low diagnosis rate of leukemia and lack of proper healthcare facilities in few Asian and African
countries is restraining growth of the leukemia therapeutics market in these regions.
For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/leukemia-
therapeutics-market-528
Key players operating in the global leukemia therapeutics market include GSK, Eisai C., Pfizer,
Biogen, Celgene, Novartis AG, Genzyme Corporation, Roche, and Bristol Myers Squibb Company
(BMS). Major market players are focused on new product launch, product pipeline, merger &
acquisitions, clinical trials and collaboration & agreements to maintain leading position in market.
For instance, Novartis recently launched tyrosine kinase receptor FLT-3 for the treatment of
leukemia. Pfizer implemented product expansion strategy to capture major market share, received
Food and Drug Approval (FDA) for Bosulif drug.
Leukemia Therapeutics Market
On the basis of disease condition, the global leukemia therapeutics market is segmented into:
•Acute lymphocytic leukemia
•Chronic lymphocytic leukemia
•Acute myeloid leukemia
•Chronic myeloid leukemia
On the basis of treatment, the global leukemia therapeutics market is segmented into:
•Immunotherapy
•Targeted Therapy
•Bone Marrow Transplant
•Stem Cell Therapy
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-
customization/528
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us: